GGrantIndex
← Leaderboards

Carla J Greenbaum

University Of Washington

Google Scholar ↗PubMed ↗ORCID ↗
$27,068,787
Attributed
$28,537,220
Total exposure
12
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.8M · FY2005–25
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$28,537,220 · 12

By mechanism

U01$24,490,902 · 3
DP3$3,051,394 · 3
R01$947,791 · 1
M01$47,133 · 5

Top collaborators

Most similar at University Of Washington

Same institution · by research overlap

Others in their field

Top investigators on “Diabetes Mellitus”

Research focus

Diabetes MellitusInsulin-Dependent Diabetes MellitusClinical TrialsInsulinClinical ResearchHuman SubjectAutoantibodiesNatural HistoryInsulin Dependent Diabetes MellitusPreventInnovationPreventionParticipantResearch InstituteScreeningInternationalBeta CellImmuneAreaConduct Clinical TrialsMediatingEnrollmentDisease /Disorder Prevention /ControlMetabolic

Grant awards (50)

Type 1 Diabetes TrialNet Clinical Network Hub$1,000,000
U01 · FY2025 · DK · contact PI
Type 1 Diabetes TrialNet Clinical Network Hub$959,999
U01 · FY2024 · DK · contact PI
Type 1 Diabetes in Acute Pancreatitis Consortium, Pacific Northwest Clinical Center: Immune Pathogenesis of Post-Pancreatitis T1D$215,625
U01 · FY2024 · DK · contact PI
Type 1 Diabetes TrialNet Clinical Network Hub$1,000,000
U01 · FY2023 · DK · contact PI
Type 1 Diabetes in Acute Pancreatitis Consortium, Pacific Northwest Clinical Center: Immune Pathogenesis of Post-Pancreatitis T1D$215,625
U01 · FY2023 · DK · contact PI
Type 1 Diabetes TrialNet Clinical Network Hub$1,000,000
U01 · FY2022 · DK · contact PI
Type 1 Diabetes in Acute Pancreatitis Consortium, Pacific Northwest Clinical Center: Immune Pathogenesis of Post-Pancreatitis T1D$215,625
U01 · FY2022 · DK · contact PI
Type 1 Diabetes in Acute Pancreatitis Consortium, Pacific Northwest Clinical Center: Immune Pathogenesis of Post-Pancreatitis T1D$215,625
U01 · FY2021 · DK · contact PI
Type 1 Diabetes TrialNet Clinical Network Hub$1,000,000
U01 · FY2020 · DK · contact PI
Type 1 Diabetes in Acute Pancreatitis Consortium, Pacific Northwest Clinical Center: Immune Pathogenesis of Post-Pancreatitis T1D$217,625
U01 · FY2020 · DK · contact PI
Type 1 Diabetes TrialNet Clinical Network Hub$1,000,000
U01 · FY2019 · DK · contact PI
Type 1 Diabetes TrialNet Clinical Network Hub$1,699,459
U01 · FY2018 · DK · contact PI
Northwest Clinical Center for Type 1 Diabetes - TrialNet$635,581
U01 · FY2018 · DK · contact PI
Type 1 Diabetes TrialNet Clinical Network Hub$1,249,031
U01 · FY2017 · DK · contact PI
Northwest Clinical Center for Type 1 Diabetes - TrialNet$584,753
U01 · FY2017 · DK · contact PI
Type 1 Diabetes TrialNet Clinical Network Hub$1,394,997
U01 · FY2016 · DK · contact PI
Northwest Clinical Center for Type 1 Diabetes - TrialNet$584,754
U01 · FY2016 · DK · contact PI
Type 1 Diabetes TrialNet Clinical Network Hub$1,425,305
U01 · FY2015 · DK · contact PI
Northwest Clinical Center for Type 1 Diabetes - TrialNet$584,754
U01 · FY2015 · DK · contact PI
Type 1 Diabetes TrialNet Clinical Network Hub$1,425,304
U01 · FY2014 · DK · contact PI
Northwest Clinical Center for Type 1 Diabetes - TrialNet$744,446
U01 · FY2014 · DK · contact PI
In Vivo Assessment of T Cell Kinetics in Individuals at Risk for Type 1 Diabetes$1,134,652
DP3 · FY2013 · DK · contact PI
Quantitative measurement of T1D risk through molecular signature analysis$856,742
DP3 · FY2013 · DK
Northwest Clinical Center for Type 1 Diabetes - TrialNet$799,561
U01 · FY2013 · DK · contact PI
AIRmax as sensitive measure of beta cell function in at-risk individuals$1,060,000
DP3 · FY2012 · DK · contact PI
Northwest Clinical Center for Type 1 Diabetes - TrialNet$603,195
U01 · FY2012 · DK · contact PI
Northwest Clinical Center for Type 1 Diabetes - TrialNet$776,175
U01 · FY2011 · DK · contact PI
Northwest Clinical Center for Type 1 Diabetes - TrialNet$865,951
U01 · FY2010 · DK · contact PI
Northwest Clinical Center for Type 1 Diabetes - TrialNet$815,951
U01 · FY2009 · DK · contact PI
Northwest Clinical Center for Type 1 Diabetes - TrialNet$985,058
U01 · FY2007 · DK · contact PI
Northwest Clinical Center for Type 1 Diabetes - TrialNet$183,093
U01 · FY2006 · DK · contact PI
Northwest Clinical Center for Type 1 Diabetes - TrialNet$625,501
U01 · FY2005 · DK
SUPPRESSION OF T CELL RESPONSE TO ISLET ANTIGENS BY IV INSULIN THERAPY$27,813
M01 · FY2005 · RR
Northwest Clinical Center for Type 1 Diabetes - TrialNet$341,523
U01 · FY2004 · DK
Northwest Clinical Center for Type 1 Diabetes - TrialNet$262,500
U01 · FY2003 · DK
Northwest Clinical Center for Type 1 Diabetes - TrialNet$267,464
U01 · FY2002 · DK
NATURAL HISTORY OF "SILENT" DIABETES$0
M01 · FY2002 · RR
BETA CELL REST TO PREVENT TYPE 1 DIABETES$0
M01 · FY2002 · RR
Northwest Clinical Center for Type 1 Diabetes - TrialNet$596,422
U01 · FY2001 · DK
DQB1*0602 RELATIVES--MECHANISMS FOR DIABETES PROTECTION$472,330
R01 · FY2001 · AI
BETA CELL REST TO PREVENT TYPE 1 DIABETES$0
M01 · FY2001 · RR
NATURAL HISTORY OF "SILENT" DIABETES$0
M01 · FY2001 · RR
DQB1*0602 RELATIVES--MECHANISMS FOR DIABETES PROTECTION$475,461
R01 · FY2000 · AI
BETA CELL REST TO PREVENT TYPE 1 DIABETES$3,864
M01 · FY2000 · RR
METABOLIC CHARACTERIZATION OF SUBJECTS WITH POST PRANDIAL DIABETES$3,864
M01 · FY2000 · RR
BETA CELL REST TO PREVENT TYPE 1 DIABETES$3,864
M01 · FY2000 · RR
NATURAL HISTORY OF SILENT DIABETES$3,864
M01 · FY2000 · RR
METABOLIC CHARACTERIZATION OF SUBJECTS WITH POST PRANDIAL DIABETES$3,864
M01 · FY2000 · RR
NATURAL HISTORY OF "SILENT" DIABETES$0
M01 · FY2000 · RR
SECRETION IN FAMILIES OF PTS W/ INSULIN DEPENDENT DIABETES$0
M01 · FY2000 · RR